Event Videos
https://www.ncbi.nlm.nih.gov/pubmed/29570556 J Pediatr Gastroenterol Nutr. 2018 Mar 22. doi: 10.1097/MPG.0000000000001950. [Epub ahead of print] Province-Wide Biliary Atresia Home Screening Program in British Columbia: Evaluation of First Two Years. Woolfson JP, Schreiber RA, Butler AE, MacFarlane J, Kaczorowski J, Masucci L, Bryan S, Collet JP. Abstract BACKGROUND: Published on:
Mar-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29604222 Hepatology. 2018 Mar 31. doi: 10.1002/hep.29905. [Epub ahead of print] BILIARY ATRESIA: Clinical and Research Challenges for the 21st Century. Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E, Sokol RJ. Abstract Published on:
Mar-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29570559 J Pediatr Gastroenterol Nutr. 2018 Mar 22. doi: 10.1097/MPG.0000000000001965. [Epub ahead of print] The Health Care Transition of Youth With Liver Disease into the Adult Health System: Position Paper from ESPGHAN and EASL. Vajro P, Fischler B, Burra P, Debray D, Dezsofi A, Guercio Nuzio S, Hadzic N, Hierro L, Jahnel J, Lamireau T, McKiernan P, McLin V, Nobili V, Socha P, Smets F, Baumann U, Verkade HJ. Abstract BACKGROUND: AIM: Published on:
Mar-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29517271 Biomark Med. 2018 Mar;12(3):265-273. doi: 10.2217/bmm-2017-0038. Epub 2018 Mar 8. The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease. Mandelia C, Kabbany MN, Conjeevaram Selvakumar PK, Alkhouri N. Abstract Published on:
Mar-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29601439 J Pediatr Gastroenterol Nutr. 2018 Mar 29. doi: 10.1097/MPG.0000000000001981. [Epub ahead of print] Neurodevelopmental Outcomes in Children With Liver Diseases: a Systematic Review. Abstract OBJECTIVE: METHOD: Published on:
Mar-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29470284 Autoimmune hepatitis Abstract OBJECTIVES: METHODS: RESULTS: Published on:
Feb-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29601441 The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease. Di Sessa A, Umano GR, Cirillo G, Del Prete A, Iacomino R, Marzuillo P, Giudice EMD. Abstract BACKGROUND: OBJECTIVES: Published on:
Mar-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29470286 NAFLD J Pediatr Gastroenterol Nutr. 2018 Feb 21. doi: 10.1097/MPG.0000000000001926. [Epub ahead of print] Abstract BACKGROUND AND OBJECTIVES: Published on:
Feb-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29601997 Contemp Clin Trials. 2018 Mar 27. pii: S1551-7144(17)30601-8. doi: 10.1016/j.cct.2018.03.014. [Epub ahead of print] Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liverdisease in adolescents with obesity: Trial design and methodology. Abstract BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder among children in the developed world and can progress to cirrhosis, hepatocellular carcinoma, and liver failure. No evidence-based dietary guidelines exist on the most effective diet prescription to treat NAFLD. OBJECTIVE: Published on:
Mar-2018
|
https://www.ncbi.nlm.nih.gov/pubmed/29470290 Autoimmune hepatitis Abstract OBJECTIVES: METHODS: RESULTS: Published on:
Feb-2018
|